Mojca Stegnar

633 total citations
16 papers, 516 citations indexed

About

Mojca Stegnar is a scholar working on Internal Medicine, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mojca Stegnar has authored 16 papers receiving a total of 516 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Internal Medicine, 5 papers in Surgery and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mojca Stegnar's work include Venous Thromboembolism Diagnosis and Management (10 papers), Blood properties and coagulation (5 papers) and Blood Coagulation and Thrombosis Mechanisms (4 papers). Mojca Stegnar is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (10 papers), Blood properties and coagulation (5 papers) and Blood Coagulation and Thrombosis Mechanisms (4 papers). Mojca Stegnar collaborates with scholars based in Slovenia, Italy and France. Mojca Stegnar's co-authors include Alenka Mavri, Janez Stare, Nina Vene, Katarina Košmelj, Polona Peternel, Irena Keber, Pavel Uhrín, Bernd R. Binder, I. Juhan‐Vague and Marie‐Christine Alessi and has published in prestigious journals such as Diabetologia, Thrombosis and Haemostasis and Thrombosis Research.

In The Last Decade

Mojca Stegnar

16 papers receiving 493 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mojca Stegnar Slovenia	8	180	141	124	113	99	16	516
Andrzej Rydzewski Poland	15	99 0.6×	187 1.3×	86 0.7×	37 0.3×	160 1.6×	57	612
Jürgen Heinrich Germany	7	167 0.9×	130 0.9×	116 0.9×	49 0.4×	213 2.2×	9	498
J.P. Collet France	7	197 1.1×	140 1.0×	107 0.9×	102 0.9×	253 2.6×	11	559
Richard C. Becker United States	13	530 2.9×	216 1.5×	99 0.8×	132 1.2×	83 0.8×	23	856
Giovanni Melandri Italy	15	461 2.6×	49 0.3×	59 0.5×	127 1.1×	103 1.0×	51	749
Vanita Tongbram United States	11	73 0.4×	73 0.5×	78 0.6×	93 0.8×	79 0.8×	34	504
Małgorzata Konieczyńska Poland	16	255 1.4×	62 0.4×	109 0.9×	90 0.8×	217 2.2×	59	769
R Schönfeld Germany	6	110 0.6×	62 0.4×	95 0.8×	26 0.2×	131 1.3×	9	449
G.J.H. den Ottolander Netherlands	10	126 0.7×	49 0.3×	72 0.6×	126 1.1×	62 0.6×	30	345
D Felmeden United Kingdom	13	314 1.7×	52 0.4×	62 0.5×	33 0.3×	64 0.6×	26	567

Countries citing papers authored by Mojca Stegnar

Since Specialization

Citations

This map shows the geographic impact of Mojca Stegnar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mojca Stegnar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mojca Stegnar more than expected).

Fields of papers citing papers by Mojca Stegnar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mojca Stegnar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mojca Stegnar. The network helps show where Mojca Stegnar may publish in the future.

Co-authorship network of co-authors of Mojca Stegnar

This figure shows the co-authorship network connecting the top 25 collaborators of Mojca Stegnar. A scholar is included among the top collaborators of Mojca Stegnar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mojca Stegnar. Mojca Stegnar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Stegnar, Mojca, Gorazd Drevenšek, Mojca Božič Mijovski, et al.. (2005). Antithrombotic potential of new direct thrombin inhibitors built on the azaphenylalanine scaffold in two rat venous thrombosis models. Thrombosis and Haemostasis. 93(3). 437–442. 5 indexed citations

Keber, Irena, et al.. (2004). Statin and fibrate treatment of combined hyperlipidemia: the effects on some novel risk factors. Thrombosis and Haemostasis. 92(11). 1129–1135. 40 indexed citations

Salobir, Barbara, Mišo Šabović, Polona Peternel, & Mojca Stegnar. (2003). Vascular Bed Specific Alterations in Coagulation and Fibrinolytic Parameters in Young Women following Myocardial Infarction, Lacunar Cerebral Infarction and Deep Vein Thrombosis. Pathophysiology of Haemostasis and Thrombosis. 33(2). 96–101. 5 indexed citations

Mijovski, Mojca Božič, et al.. (2003). Fibrinogen Polymorphisms Taq I, Hae III and Bcl I Are Not Associated with a Higher Risk of Deep Vein Thrombosis. Pathophysiology of Haemostasis and Thrombosis. 33(3). 164–169. 5 indexed citations

Mavri, Alenka, Katarina Košmelj, Mojca Stegnar, & Nina Vene. (2003). High D-dimer levels predict cardiovascular events in patients with chronic atrial fibrillation during oral anticoagulant therapy. Thrombosis and Haemostasis. 90(12). 1163–1172. 86 indexed citations

Mavri, Alenka, et al.. (2001). Impact of Weight Reduction on Early Carotid Atherosclerosis in Obese Premenopausal Women. Obesity Research. 9(9). 511–516. 41 indexed citations

Mavri, Alenka, et al.. (2001). Seasonal variation of some metabolic and haemostatic risk factors in subjects with and without coronary artery disease. Blood Coagulation & Fibrinolysis. 12(5). 359–365. 68 indexed citations

Mavri, Alenka, et al.. (2001). Subcutaneous abdominal, but not femoral fat expression of plasminogen activator inhibitor-1 (PAI-1) is related to plasma PAI-1 levels and insulin resistance and decreases after weight loss. Diabetologia. 44(11). 2025–2031. 91 indexed citations

Mijovski, Mojca Božič, Mojca Stegnar, Isabella Fermo, et al.. (2000). Mild Hyperhomocysteinemia and Fibrinolytic Factors in Patients with History of Venous Thromboembolism. Thrombosis Research. 100(4). 271–278. 13 indexed citations

10.

Stegnar, Mojca, Pavel Uhrín, Polona Peternel, et al.. (1998). The 4G/5G Sequence Polymorphism in the Promoter of Plasminogen Activator Inhibitor-1 (PAI-1) Gene: Relationship to Plasma PAI-1 Level in Venous Thromboembolism. Thrombosis and Haemostasis. 79(5). 975–979. 109 indexed citations

11.

Stegnar, Mojca, et al.. (1993). Tissue-Type Plasminogen Activator after Venous Occlusion in Pregnancy and Puerperium. Thrombosis and Haemostasis. 70(3). 486–490. 3 indexed citations

12.

Blinc, Aleš, D. Keber, G. Lahajnar, et al.. (1992). Lysing Patterns of Retracted Blood Clots with Diffusion or Bulk Flow Transport of Plasma with Urokinase into Clots – a Magnetic Resonance Imaging Study In Vitro. Thrombosis and Haemostasis. 68(6). 667–671. 44 indexed citations

13.

Keber, Irena, et al.. (1992). Fibrinolytic system in different hyperlipidemias before and after arm venous occlusion. Thrombosis Research. 65. S93–S93. 1 indexed citations

14.

Stegnar, Mojca, Polona Peternel, & Nina Vene. (1990). Poor response to venous occlusion by different criteria in deep vein thrombosis. Fibrinolysis and Proteolysis. 4. 70–70. 1 indexed citations

15.

Keber, D., Zlatko Fras, & Mojca Stegnar. (1988). 97 Separate and joint effect of physical activity and DDAVP infusion on the release of tissue plasminogen activator. Fibrinolysis and Proteolysis. 2. 44–44. 3 indexed citations

16.

Stegnar, Mojca, et al.. (1981). Relation of blood coagulation, fibrinolysis and platelet aggregation tests to development of deep vein thrombosis in high risk medical patients.. PubMed. 35(4). 259–67. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact